20WAYS to Improve Pa tient Care & Pharmacy cost containment Fagron’s SyrSpend® SF: Innovative Compounding Suspension Concept SyrSpend® SF brings added value in compounding oral suspensions: superior suspendability for more accurate dosing, better taste, extensive scientific stability data and can improve compliance, all while reducing inventory and carrying costs. Summer 2014 I heal th system • infusi on 31 General Manager: Marije van Dalen Founded: 1980 Employees: 60+ Toll-free Phone: (800) 423-6967 Fax: (800) 339-1596 Address: 2400 Pilot Knob Road St. Paul, MN 55120 Website: Order online at fagron.us Company Background Fagron, Inc. provides pharmacists in the United States with high quality compounding products and solutions. Fagron continuously introduces innovative products based on research done in our own R&D center. We work together with our customers, universities, physicians and other healthcare providers to deliver optimized compounding solutions with high quality results. We continuously perform studies on our products, dedicated to providing you with innovative compounding solutions. Based in St. Paul, MN, Fagron, Inc. is part of the Fagron Group, the global market leader in pharmaceutical compounding, headquartered in the Netherlands. With over 1,300 employees in 30 countries worldwide, Fagron Group provides over 200,000 pharmacists with high quality compounding products every day. Product Overview The SyrSpend® SF family of products is an innovative line of oral suspension vehicles. SyrSpend® SF’s patented Active Suspending Technology™ holds API particles in suspension longer and accelerates redistribution of suspended medication with a simple shake for more accurate dosing at each administration. Our Product Line Consists of: • SyrSpend® SF, a sugar-free suspending vehicle buffered to a pH of 4.2 for maximum compatibility with active pharmaceutical ingredients. Preservative-free version available. • SyrSpend® SF Alka, an easy-to-use powder for reconstitution that provides an alkaline environment for acid-labile drugs such as omeprazole. • Omeprazole + SyrSpend® SF Cherry Alka Kit, an all-in-one compounding kit for preparing a pleasant-tasting 2 mg/ml omeprazole suspension in minutes. It comes with pre-weighed ingredients and preparation and administration tools, eliminating weighing and saving time. Benefits of SyrSpend® SF • Convenient, all-in-one suspending vehicles. • Optimizes ease of administration, mouth feel and taste masking. • Meticulous ingredient choice: formulated without alcohol, parabens, sorbitol, sugars, gluten or dyes. • Ideal for individualized dosage regimens. • Low osmolality (<50 mOsm), minimizing gastrointestinal upset and diarrhea. • Patented Active Suspending Technology™ to hold API particles in suspension longer for more accurate and consistent dosing during treatment. • Suitable for diabetic patients. • Extensive and growing database of stability data. • Produced in a GMP-certified and FDA registered facility with pharmaceutically-tested ingredients. Stability Studies Fagron, Inc. continuously performs stability studies to provide our customers with extended beyond-use dating. The studies are being published in renowned peer-reviewed journals. n Documented Beyond Use Date (BUD) in SyrSpend® SF Studied Drugs Include:* • Vancomycin - 90 Days Refrigerated • Verapamil HCI - 60 Days Refrigerated • Metronidazole Benzoate - Two Years Refrigerated, One Year Room Temperature • Oseltamivir Phosphate - 30 Days Refrigerated • Gabapentin - 120 Days Refrigerated, 90 Days Room Temperature • Propranolol HCI - 90 Days Refrigerated • Ursodiol - 66 Days Refrigerated • Rifampin - 60 Days Refrigerated and Room Temperature • Midazolam - 58 Days Refrigerated and Room Temperature • Captopril - 14 Days Refrigerated n Documented Beyond Use Date (BUD) on SyrSpend® SF Alka Studied Drugs Include:* • Omeprazole - 60 Days Refrigerated Visit fagron.us for more information. * Literature references available. Specific questions with regard to the products or their beyond use date should be directed solely to Fagron, Inc., its representatives or distributors.
20Ways Summer 2014 Hospital Edition
To see the actual publication please follow the link above